Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
Camber Pharmaceuticals has launched Buprenorphine and Naloxone Sublingual Tablets [BUE-pre-NOR-feen and nal-OX-one suhb-ling-gwl], generic for Suboxone®.
Available in 2 mg/0.5 mg and 8 mg/2mg strengths in 30 count bottles, Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and Naloxone Sublingual Tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.
See full prescribing information for the safe use of Buprenorphine and Naloxone Sublingual Tablets here.
Click To Learn More About Buprenorphine and Naloxone Sublingual Tablets.
Recent articles
- New Product Launch: Clomiphene Citrate Tablets, USP
- Camber Launches Raltegravir Tablets 400 mg
- Specialty Generics: Where Access Meets Affordability
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
- New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets





